Skip to main content
. 2017 Dec 29;34(2):207–212. doi: 10.1007/s12291-017-0731-9

Table 1.

Clinicopathological demographic data of the Prostate cancer and BPH patient

Clinical characteristic’s Prostate cancer (N = 50) BPH (N = 40)
Age
 < 60 20 (40%) 13 (32.5%)
 ≥ 60 30 (60%) 27 (67.5%)
PSA level (ng/ml)
 Median < 20 16 (32.00%) 36 (90%)
 High ≥ 20 34 (68.00%) 4 (10%)
Gleason Score
 ≤ 7a 29(58.00%)
 > 7b 21 (42.00%)
Metastasis
 Mc0 33 (66.00%)
 Mxd 17 (33.00%)

a≤ 7 = Low Gleason Score

b> 7 = High Gleason Score

cM0 = Non metastatic condition

dMx = Metastatic condition